Filing Flows › Orthofix Medical (OFIX) › Q4 FY24
Orthofix Medical (OFIX) Q4 FY24 earnings results (fourth quarter fiscal 2024)
10-K filed Feb 25, 2025
Orthofix Medical (OFIX) reported revenue of $216M for the fourth quarter fiscal 2024 (Q4 FY24), +8% from a year earlier and +10% from the quarter before. Operating margin was -5.3%, net loss $29.1M (13.5% of revenue).
Orthofix Medical, Q4 FY24: revenue $216M (+8% year over year), operating margin -5.3%, net loss $29.1M, operating cash flow $23.7M. The chart follows the revenue to costs, profit and cash.
| Q4 FY24 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $216M | +10% | +8% |
| Operating profit | −$11.5M | — | — |
| Net earnings | −$29.1M | — | — |
| Operating cash flow | $23.7M | +103% | — |
| Free cash flow | $15.2M | +159% | — |
What changed
Revenue was $215.7M in Q4 FY24, up 8% year over year and up 10% from the previous quarter. Global Spine was the largest line at 83% of revenue.
Gross margin was 69.0%, up 0.8 points from a year earlier. Operating costs exceeded revenue by $11.5M, an operating margin of -5.3%. Operating expenses grew 3% against revenue growth of 8%. The fastest-growing cost line was Other operating costs (+35%). The quarter ended with a net loss of $29.1M, wider than the previous quarter's $27.4M loss. Net interest and other expense of $18.2M was the main reason.
Operating cash flow was $23.7M. Non-cash charges added back $16.0M of depreciation and amortization and $7.2M of share-based compensation. Working capital and other items added $29.7M. Capital expenditures of $8.5M left free cash flow of $15.2M.
Questions
What was Orthofix Medical's revenue in the fourth quarter fiscal 2024?
Orthofix Medical (OFIX) reported revenue of $216M for the fourth quarter fiscal 2024 (Q4 FY24), +8% from a year earlier and +10% from the quarter before.
Was Orthofix Medical profitable in the fourth quarter fiscal 2024?
Operating loss was $11.5M (-5.3% of revenue) and net loss $29.1M.
Source: Orthofix Medical 10-K on SEC EDGAR.